Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 198 entries
Sorted by: Best Match Show Resources per page
Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.

Nature communications

Ghoussaini M, Edwards SL, Michailidou K, Nord S, Cowper-Sal Lari R, Desai K, Kar S, Hillman KM, Kaufmann S, Glubb DM, Beesley J, Dennis J, Bolla MK, Wang Q, Dicks E, Guo Q, Schmidt MK, Shah M, Luben R, Brown J, Czene K, Darabi H, Eriksson M, Klevebring D, Bojesen SE, Nordestgaard BG, Nielsen SF, Flyger H, Lambrechts D, Thienpont B, Neven P, Wildiers H, Broeks A, Van't Veer LJ, Rutgers EJT, Couch FJ, Olson JE, Hallberg E, Vachon C, Chang-Claude J, Rudolph A, Seibold P, Flesch-Janys D, Peto J, Dos-Santos-Silva I, Gibson L, Nevanlinna H, Muranen TA, Aittomäki K, Blomqvist C, Hall P, Li J, Liu J, Humphreys K, Kang D, Choi JY, Park SK, Noh DY, Matsuo K, Ito H, Iwata H, Yatabe Y, Guénel P, Truong T, Menegaux F, Sanchez M, Burwinkel B, Marme F, Schneeweiss A, Sohn C, Wu AH, Tseng CC, Van Den Berg D, Stram DO, Benitez J, Pilar Zamora M, Perez JIA, Menéndez P, Shu XO, Lu W, Gao YT, Cai Q, Cox A, Cross SS, Reed MWR, Andrulis IL, Knight JA, Glendon G, Tchatchou S, Sawyer EJ, Tomlinson I, Kerin MJ, Miller N, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Lindblom A, Margolin S, Teo SH, Yip CH, Lee DSC, Wong TY, Hooning MJ, Martens JWM, Collée JM, van Deurzen CHM, Hopper JL, Southey MC, Tsimiklis H, Kapuscinski MK, Shen CY, Wu PE, Yu JC, Chen ST, Alnæs GG, Borresen-Dale AL, Giles GG, Milne RL, McLean C, Muir K, Lophatananon A, Stewart-Brown S, Siriwanarangsan P, Hartman M, Miao H, Buhari SABS, Teo YY, Fasching PA, Haeberle L, Ekici AB, Beckmann MW, Brenner H, Dieffenbach AK, Arndt V, Stegmaier C, Swerdlow A, Ashworth A, Orr N, Schoemaker MJ, García-Closas M, Figueroa J, Chanock SJ, Lissowska J, Simard J, Goldberg MS, Labrèche F, Dumont M, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Brauch H, Brüning T, Koto YD, Radice P, Peterlongo P, Bonanni B, Volorio S, Dörk T, Bogdanova NV, Helbig S, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Devilee P, Tollenaar RAEM, Seynaeve C, Van Asperen CJ, Jakubowska A, Lubinski J, Jaworska-Bieniek K, Durda K, Slager S, Toland AE, Ambrosone CB, Yannoukakos D, Sangrajrang S, Gaborieau V, Brennan P, McKay J, Hamann U, Torres D, Zheng W, Long J, Anton-Culver H, Neuhausen SL, Luccarini C, Baynes C, Ahmed S, Maranian M, Healey CS, González-Neira A, Pita G, Rosario Alonso M, Álvarez N, Herrero D, Tessier DC, Vincent D, Bacot F, de Santiago I, Carroll J, Caldas C, Brown MA, Lupien M, Kristensen VN, Pharoah PDP, Chenevix-Trench G, French JD, Easton DF, Dunning AM.
PMID: 29633761
Nat Commun. 2018 Apr 10;9:16193. doi: 10.1038/ncomms16193.

This corrects the article DOI: 10.1038/ncomms5999.

Cite
Ghoussaini M, Edwards SL, Michailidou K, et al. Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. Nat Commun. 2018;9:16193doi: 10.1038/ncomms16193.
Ghoussaini, M., Edwards, S. L., Michailidou, K., Nord, S., Cowper-Sal Lari, R., Desai, K., Kar, S., Hillman, K. M., Kaufmann, S., Glubb, D. M., Beesley, J., Dennis, J., Bolla, M. K., Wang, Q., Dicks, E., Guo, Q., Schmidt, M. K., Shah, M., Luben, R., Brown, J., Czene, K., Darabi, H., Eriksson, M., Klevebring, D., Bojesen, S. E., Nordestgaard, B. G., Nielsen, S. F., Flyger, H., Lambrechts, D., Thienpont, B., Neven, P., Wildiers, H., Broeks, A., Van't Veer, L. J., Rutgers, E. J. T., Couch, F. J., Olson, J. E., Hallberg, E., Vachon, C., Chang-Claude, J., Rudolph, A., Seibold, P., Flesch-Janys, D., Peto, J., Dos-Santos-Silva, I., Gibson, L., Nevanlinna, H., Muranen, T. A., Aittomäki, K., Blomqvist, C., Hall, P., Li, J., Liu, J., Humphreys, K., Kang, D., Choi, J. Y., Park, S. K., Noh, D. Y., Matsuo, K., Ito, H., Iwata, H., Yatabe, Y., Guénel, P., Truong, T., Menegaux, F., Sanchez, M., Burwinkel, B., Marme, F., Schneeweiss, A., Sohn, C., Wu, A. H., Tseng, C. C., Van Den Berg, D., Stram, D. O., Benitez, J., Pilar Zamora, M., Perez, J. I. A., Menéndez, P., Shu, X. O., Lu, W., Gao, Y. T., Cai, Q., Cox, A., Cross, S. S., Reed, M. W. R., Andrulis, I. L., Knight, J. A., Glendon, G., Tchatchou, S., Sawyer, E. J., Tomlinson, I., Kerin, M. J., Miller, N., Haiman, C. A., Henderson, B. E., Schumacher, F., Le Marchand, L., Lindblom, A., Margolin, S., Teo, S. H., Yip, C. H., Lee, D. S. C., Wong, T. Y., Hooning, M. J., Martens, J. W. M., Collée, J. M., van Deurzen, C. H. M., Hopper, J. L., Southey, M. C., Tsimiklis, H., Kapuscinski, M. K., Shen, C. Y., Wu, P. E., Yu, J. C., Chen, S. T., Alnæs, G. G., Borresen-Dale, A. L., Giles, G. G., Milne, R. L., McLean, C., Muir, K., Lophatananon, A., Stewart-Brown, S., Siriwanarangsan, P., Hartman, M., Miao, H., Buhari, S. A. B. S., Teo, Y. Y., Fasching, P. A., Haeberle, L., Ekici, A. B., Beckmann, M. W., Brenner, H., Dieffenbach, A. K., Arndt, V., Stegmaier, C., Swerdlow, A., Ashworth, A., Orr, N., Schoemaker, M. J., García-Closas, M., Figueroa, J., Chanock, S. J., Lissowska, J., Simard, J., Goldberg, M. S., Labrèche, F., Dumont, M., Winqvist, R., Pylkäs, K., Jukkola-Vuorinen, A., Brauch, H., Brüning, T., Koto, Y. D., Radice, P., Peterlongo, P., Bonanni, B., Volorio, S., Dörk, T., Bogdanova, N. V., Helbig, S., Mannermaa, A., Kataja, V., Kosma, V. M., Hartikainen, J. M., Devilee, P., Tollenaar, R. A. E. M., Seynaeve, C., Van Asperen, C. J., Jakubowska, A., Lubinski, J., Jaworska-Bieniek, K., Durda, K., Slager, S., Toland, A. E., Ambrosone, C. B., Yannoukakos, D., Sangrajrang, S., Gaborieau, V., Brennan, P., McKay, J., Hamann, U., Torres, D., Zheng, W., Long, J., Anton-Culver, H., Neuhausen, S. L., Luccarini, C., Baynes, C., Ahmed, S., Maranian, M., Healey, C. S., González-Neira, A., Pita, G., Rosario Alonso, M., Álvarez, N., Herrero, D., Tessier, D. C., Vincent, D., Bacot, F., de Santiago, I., Carroll, J., Caldas, C., Brown, M. A., Lupien, M., Kristensen, V. N., Pharoah, P. D. P., Chenevix-Trench, G., French, J. D., Easton, D. F., & Dunning, A. M. (2018). Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. Nature communications, 916193. https://doi.org/10.1038/ncomms16193
Ghoussaini, Maya, et al. "Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation." Nature communications vol. 9 (2018): 16193. doi: https://doi.org/10.1038/ncomms16193
Ghoussaini M, Edwards SL, Michailidou K, Nord S, Cowper-Sal Lari R, Desai K, Kar S, Hillman KM, Kaufmann S, Glubb DM, Beesley J, Dennis J, Bolla MK, Wang Q, Dicks E, Guo Q, Schmidt MK, Shah M, Luben R, Brown J, Czene K, Darabi H, Eriksson M, Klevebring D, Bojesen SE, Nordestgaard BG, Nielsen SF, Flyger H, Lambrechts D, Thienpont B, Neven P, Wildiers H, Broeks A, Van't Veer LJ, Rutgers EJT, Couch FJ, Olson JE, Hallberg E, Vachon C, Chang-Claude J, Rudolph A, Seibold P, Flesch-Janys D, Peto J, Dos-Santos-Silva I, Gibson L, Nevanlinna H, Muranen TA, Aittomäki K, Blomqvist C, Hall P, Li J, Liu J, Humphreys K, Kang D, Choi JY, Park SK, Noh DY, Matsuo K, Ito H, Iwata H, Yatabe Y, Guénel P, Truong T, Menegaux F, Sanchez M, Burwinkel B, Marme F, Schneeweiss A, Sohn C, Wu AH, Tseng CC, Van Den Berg D, Stram DO, Benitez J, Pilar Zamora M, Perez JIA, Menéndez P, Shu XO, Lu W, Gao YT, Cai Q, Cox A, Cross SS, Reed MWR, Andrulis IL, Knight JA, Glendon G, Tchatchou S, Sawyer EJ, Tomlinson I, Kerin MJ, Miller N, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Lindblom A, Margolin S, Teo SH, Yip CH, Lee DSC, Wong TY, Hooning MJ, Martens JWM, Collée JM, van Deurzen CHM, Hopper JL, Southey MC, Tsimiklis H, Kapuscinski MK, Shen CY, Wu PE, Yu JC, Chen ST, Alnæs GG, Borresen-Dale AL, Giles GG, Milne RL, McLean C, Muir K, Lophatananon A, Stewart-Brown S, Siriwanarangsan P, Hartman M, Miao H, Buhari SABS, Teo YY, Fasching PA, Haeberle L, Ekici AB, Beckmann MW, Brenner H, Dieffenbach AK, Arndt V, Stegmaier C, Swerdlow A, Ashworth A, Orr N, Schoemaker MJ, García-Closas M, Figueroa J, Chanock SJ, Lissowska J, Simard J, Goldberg MS, Labrèche F, Dumont M, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Brauch H, Brüning T, Koto YD, Radice P, Peterlongo P, Bonanni B, Volorio S, Dörk T, Bogdanova NV, Helbig S, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Devilee P, Tollenaar RAEM, Seynaeve C, Van Asperen CJ, Jakubowska A, Lubinski J, Jaworska-Bieniek K, Durda K, Slager S, Toland AE, Ambrosone CB, Yannoukakos D, Sangrajrang S, Gaborieau V, Brennan P, McKay J, Hamann U, Torres D, Zheng W, Long J, Anton-Culver H, Neuhausen SL, Luccarini C, Baynes C, Ahmed S, Maranian M, Healey CS, González-Neira A, Pita G, Rosario Alonso M, Álvarez N, Herrero D, Tessier DC, Vincent D, Bacot F, de Santiago I, Carroll J, Caldas C, Brown MA, Lupien M, Kristensen VN, Pharoah PDP, Chenevix-Trench G, French JD, Easton DF, Dunning AM. Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. Nat Commun. 2018 Apr 10;9:16193. doi: 10.1038/ncomms16193. PMID: 29633761; PMCID: PMC5898457.
Copy Download .nbib Format: NLM
Measurement Instrument for Scientific Teaching (MIST): A Tool to Measure the Frequencies of Research-Based Teaching Practices in Undergraduate Science Courses.

CBE life sciences education

Durham MF, Knight JK, Couch BA.
PMID: 29196428
CBE Life Sci Educ. 2017;16(4). doi: 10.1187/cbe.17-02-0033.

The Scientific Teaching (ST) pedagogical framework provides various approaches for science instructors to teach in a way that more closely emulates how science is practiced by actively and inclusively engaging students in their own learning and by making instructional...

Cite
Durham MF, Knight JK, Couch BA. Measurement Instrument for Scientific Teaching (MIST): A Tool to Measure the Frequencies of Research-Based Teaching Practices in Undergraduate Science Courses. CBE Life Sci Educ. 2017;16(4)doi: 10.1187/cbe.17-02-0033.
Durham, M. F., Knight, J. K., & Couch, B. A. (2017). Measurement Instrument for Scientific Teaching (MIST): A Tool to Measure the Frequencies of Research-Based Teaching Practices in Undergraduate Science Courses. CBE life sciences education, 16(4), . https://doi.org/10.1187/cbe.17-02-0033
Durham, Mary F, et al. "Measurement Instrument for Scientific Teaching (MIST): A Tool to Measure the Frequencies of Research-Based Teaching Practices in Undergraduate Science Courses." CBE life sciences education vol. 16,4 (2017). doi: https://doi.org/10.1187/cbe.17-02-0033
Durham MF, Knight JK, Couch BA. Measurement Instrument for Scientific Teaching (MIST): A Tool to Measure the Frequencies of Research-Based Teaching Practices in Undergraduate Science Courses. CBE Life Sci Educ. 2017;16(4). doi: 10.1187/cbe.17-02-0033. PMID: 29196428; PMCID: PMC5749969.
Copy Download .nbib Format: NLM
Erratum to: Mammographic texture and risk of breast cancer by tumor type and estrogen receptor status.

Breast cancer research : BCR

Malkov S, Shepherd JA, Scott CG, Tamimi RM, Ma L, Bertrand KA, Couch F, Jensen MR, Mahmoudzadeh AP, Fan B, Norman A, Brandt KR, Pankratz VS, Vachon CM, Kerlikowske K.
PMID: 28052757
Breast Cancer Res. 2017 Jan 04;19(1):1. doi: 10.1186/s13058-016-0797-y.

No abstract available.

Cite
Malkov S, Shepherd JA, Scott CG, et al. Erratum to: Mammographic texture and risk of breast cancer by tumor type and estrogen receptor status. Breast Cancer Res. 2017;19(1):1doi: 10.1186/s13058-016-0797-y.
Malkov, S., Shepherd, J. A., Scott, C. G., Tamimi, R. M., Ma, L., Bertrand, K. A., Couch, F., Jensen, M. R., Mahmoudzadeh, A. P., Fan, B., Norman, A., Brandt, K. R., Pankratz, V. S., Vachon, C. M., & Kerlikowske, K. (2017). Erratum to: Mammographic texture and risk of breast cancer by tumor type and estrogen receptor status. Breast cancer research : BCR, 19(1), 1. https://doi.org/10.1186/s13058-016-0797-y
Malkov, Serghei, et al. "Erratum to: Mammographic texture and risk of breast cancer by tumor type and estrogen receptor status." Breast cancer research : BCR vol. 19,1 (2017): 1. doi: https://doi.org/10.1186/s13058-016-0797-y
Malkov S, Shepherd JA, Scott CG, Tamimi RM, Ma L, Bertrand KA, Couch F, Jensen MR, Mahmoudzadeh AP, Fan B, Norman A, Brandt KR, Pankratz VS, Vachon CM, Kerlikowske K. Erratum to: Mammographic texture and risk of breast cancer by tumor type and estrogen receptor status. Breast Cancer Res. 2017 Jan 04;19(1):1. doi: 10.1186/s13058-016-0797-y. PMID: 28052757; PMCID: PMC5209878.
Copy Download .nbib Format: NLM
Perceived Flavored Smokeless Tobacco Ease-of-use and Youth Susceptibility.

Tobacco regulatory science

Chaffee BW, Urata J, Couch ET, Gansky SA.
PMID: 28781992
Tob Regul Sci. 2017 Jul;3(3):367-373. doi: 10.18001/TRS.3.3.12.

OBJECTIVES: Beliefs that flavored smokeless tobacco (ST) is more pleasant, less potent, or otherwise easier to use could contribute to youth initiation. We evaluated associations between perceived ease-of-use of flavored ST (moist snuff and chewing tobacco) and ST initiation...

Cite
Chaffee BW, Urata J, Couch ET, et al. Perceived Flavored Smokeless Tobacco Ease-of-use and Youth Susceptibility. Tob Regul Sci. 2017;3(3):367-373doi: 10.18001/TRS.3.3.12.
Chaffee, B. W., Urata, J., Couch, E. T., & Gansky, S. A. (2017). Perceived Flavored Smokeless Tobacco Ease-of-use and Youth Susceptibility. Tobacco regulatory science, 3(3), 367-373. https://doi.org/10.18001/TRS.3.3.12
Chaffee, Benjamin W, et al. "Perceived Flavored Smokeless Tobacco Ease-of-use and Youth Susceptibility." Tobacco regulatory science vol. 3,3 (2017): 367-373. doi: https://doi.org/10.18001/TRS.3.3.12
Chaffee BW, Urata J, Couch ET, Gansky SA. Perceived Flavored Smokeless Tobacco Ease-of-use and Youth Susceptibility. Tob Regul Sci. 2017 Jul;3(3):367-373. doi: 10.18001/TRS.3.3.12. PMID: 28781992; PMCID: PMC5539957.
Copy Download .nbib Format: NLM
Multigene Hereditary Cancer Panels Reveal High-Risk Pancreatic Cancer Susceptibility Genes.

JCO precision oncology

Hu C, LaDuca H, Shimelis H, Polley EC, Lilyquist J, Hart SN, Na J, Thomas A, Lee KY, Davis BT, Black MH, Pesaran T, Goldgar DE, Dolinsky JS, Couch FJ.
PMID: 31497750
JCO Precis Oncol. 2018;2. doi: 10.1200/PO.17.00291. Epub 2018 Jul 25.

PURPOSE: The relevance of inherited pathogenic mutations in cancer predisposition genes in pancreatic cancer is not well understood. We aimed to assess the characteristics of patients with pancreatic cancer referred for hereditary cancer genetic testing and to estimate the...

Cite
Hu C, LaDuca H, Shimelis H, et al. Multigene Hereditary Cancer Panels Reveal High-Risk Pancreatic Cancer Susceptibility Genes. JCO Precis Oncol. 2018;2doi: 10.1200/PO.17.00291.
Hu, C., LaDuca, H., Shimelis, H., Polley, E. C., Lilyquist, J., Hart, S. N., Na, J., Thomas, A., Lee, K. Y., Davis, B. T., Black, M. H., Pesaran, T., Goldgar, D. E., Dolinsky, J. S., & Couch, F. J. (2018). Multigene Hereditary Cancer Panels Reveal High-Risk Pancreatic Cancer Susceptibility Genes. JCO precision oncology, 2. https://doi.org/10.1200/PO.17.00291
Hu, Chunling, et al. "Multigene Hereditary Cancer Panels Reveal High-Risk Pancreatic Cancer Susceptibility Genes." JCO precision oncology vol. 2 (2018). doi: https://doi.org/10.1200/PO.17.00291
Hu C, LaDuca H, Shimelis H, Polley EC, Lilyquist J, Hart SN, Na J, Thomas A, Lee KY, Davis BT, Black MH, Pesaran T, Goldgar DE, Dolinsky JS, Couch FJ. Multigene Hereditary Cancer Panels Reveal High-Risk Pancreatic Cancer Susceptibility Genes. JCO Precis Oncol. 2018;2. doi: 10.1200/PO.17.00291. Epub 2018 Jul 25. PMID: 31497750; PMCID: PMC6731034.
Copy Download .nbib Format: NLM
Limited-edition smokeless tobacco packaging: Behind the camouflage.

Tobacco induced diseases

Couch ET, Urata J, Chaffee BW.
PMID: 31582947
Tob Induc Dis. 2019 Aug 02;17:58. doi: 10.18332/tid/110676. eCollection 2019.

No abstract available.

Cite
Couch ET, Urata J, Chaffee BW. Limited-edition smokeless tobacco packaging: Behind the camouflage. Tob Induc Dis. 2019;17:58doi: 10.18332/tid/110676.
Couch, E. T., Urata, J., & Chaffee, B. W. (2019). Limited-edition smokeless tobacco packaging: Behind the camouflage. Tobacco induced diseases, 1758. https://doi.org/10.18332/tid/110676
Couch, Elizabeth T, et al. "Limited-edition smokeless tobacco packaging: Behind the camouflage." Tobacco induced diseases vol. 17 (2019): 58. doi: https://doi.org/10.18332/tid/110676
Couch ET, Urata J, Chaffee BW. Limited-edition smokeless tobacco packaging: Behind the camouflage. Tob Induc Dis. 2019 Aug 02;17:58. doi: 10.18332/tid/110676. eCollection 2019. PMID: 31582947; PMCID: PMC6770615.
Copy Download .nbib Format: NLM
Early myoclonus following anoxic brain injury.

Neurology. Clinical practice

Reynolds AS, Rohaut B, Holmes MG, Robinson D, Roth W, Velazquez A, Couch CK, Presciutti A, Brodie D, Moitra VK, Rabbani LE, Agarwal S, Park S, Roh DJ, Claassen J.
PMID: 30105165
Neurol Clin Pract. 2018 Jun;8(3):249-256. doi: 10.1212/CPJ.0000000000000466.

BACKGROUND: It is unknown whether postanoxic cortical and subcortical myoclonus are distinct entities with different prognoses.METHODS: In this retrospective cohort study of 604 adult survivors of cardiac arrest over 8.5 years, we identified 111 (18%) patients with myoclonus. Basic...

Cite
Reynolds AS, Rohaut B, Holmes MG, et al. Early myoclonus following anoxic brain injury. Neurol Clin Pract. 2018;8(3):249-256doi: 10.1212/CPJ.0000000000000466.
Reynolds, A. S., Rohaut, B., Holmes, M. G., Robinson, D., Roth, W., Velazquez, A., Couch, C. K., Presciutti, A., Brodie, D., Moitra, V. K., Rabbani, L. E., Agarwal, S., Park, S., Roh, D. J., & Claassen, J. (2018). Early myoclonus following anoxic brain injury. Neurology. Clinical practice, 8(3), 249-256. https://doi.org/10.1212/CPJ.0000000000000466
Reynolds, Alexandra S, et al. "Early myoclonus following anoxic brain injury." Neurology. Clinical practice vol. 8,3 (2018): 249-256. doi: https://doi.org/10.1212/CPJ.0000000000000466
Reynolds AS, Rohaut B, Holmes MG, Robinson D, Roth W, Velazquez A, Couch CK, Presciutti A, Brodie D, Moitra VK, Rabbani LE, Agarwal S, Park S, Roh DJ, Claassen J. Early myoclonus following anoxic brain injury. Neurol Clin Pract. 2018 Jun;8(3):249-256. doi: 10.1212/CPJ.0000000000000466. PMID: 30105165; PMCID: PMC6075972.
Copy Download .nbib Format: NLM
Genetic Variations and Health-Related Quality of Life (HRQOL): A Genome-Wide Study Approach.

Cancers

Adjei AA, Lopez CL, Schaid DJ, Sloan JA, Le-Rademacher JG, Loprinzi CL, Norman AD, Olson JE, Couch FJ, Beutler AS, Vachon CM, Ruddy KJ.
PMID: 33578652
Cancers (Basel). 2021 Feb 10;13(4). doi: 10.3390/cancers13040716.

Health-related quality of life (HRQOL) is an important prognostic patient-reported outcome in oncology. Because prior studies suggest that HRQOL is, in part, heritable, we performed a GWAS to elucidate genetic factors associated with HRQOL in breast cancer survivors. Physical...

Cite
Adjei AA, Lopez CL, Schaid DJ, et al. Genetic Variations and Health-Related Quality of Life (HRQOL): A Genome-Wide Study Approach. Cancers (Basel). 2021;13(4)doi: 10.3390/cancers13040716.
Adjei, A. A., Lopez, C. L., Schaid, D. J., Sloan, J. A., Le-Rademacher, J. G., Loprinzi, C. L., Norman, A. D., Olson, J. E., Couch, F. J., Beutler, A. S., Vachon, C. M., & Ruddy, K. J. (2021). Genetic Variations and Health-Related Quality of Life (HRQOL): A Genome-Wide Study Approach. Cancers, 13(4), . https://doi.org/10.3390/cancers13040716
Adjei, Araba A, et al. "Genetic Variations and Health-Related Quality of Life (HRQOL): A Genome-Wide Study Approach." Cancers vol. 13,4 (2021). doi: https://doi.org/10.3390/cancers13040716
Adjei AA, Lopez CL, Schaid DJ, Sloan JA, Le-Rademacher JG, Loprinzi CL, Norman AD, Olson JE, Couch FJ, Beutler AS, Vachon CM, Ruddy KJ. Genetic Variations and Health-Related Quality of Life (HRQOL): A Genome-Wide Study Approach. Cancers (Basel). 2021 Feb 10;13(4). doi: 10.3390/cancers13040716. PMID: 33578652; PMCID: PMC7916362.
Copy Download .nbib Format: NLM
A Phase 1 study of GDC-0134, a dual leucine zipper kinase inhibitor, in ALS.

Annals of clinical and translational neurology

Katz JS, Rothstein JD, Cudkowicz ME, Genge A, Oskarsson B, Hains AB, Chen C, Galanter J, Burgess BL, Cho W, Kerchner GA, Yeh FL, Ghosh AS, Cheeti S, Brooks L, Honigberg L, Couch JA, Rothenberg ME, Brunstein F, Sharma KR, van den Berg L, Berry JD, Glass JD.
PMID: 35014217
Ann Clin Transl Neurol. 2022 Jan 10; doi: 10.1002/acn3.51491. Epub 2022 Jan 10.

OBJECTIVE: Dual leucine zipper kinase (DLK), which regulates the c-Jun N-terminal kinase pathway involved in axon degeneration and apoptosis following neuronal injury, is a potential therapeutic target in amyotrophic lateral sclerosis (ALS). This first-in-human study investigated safety, tolerability, and...

Cite
Katz JS, Rothstein JD, Cudkowicz ME, et al. A Phase 1 study of GDC-0134, a dual leucine zipper kinase inhibitor, in ALS. Ann Clin Transl Neurol. 2022;doi: 10.1002/acn3.51491.
Katz, J. S., Rothstein, J. D., Cudkowicz, M. E., Genge, A., Oskarsson, B., Hains, A. B., Chen, C., Galanter, J., Burgess, B. L., Cho, W., Kerchner, G. A., Yeh, F. L., Ghosh, A. S., Cheeti, S., Brooks, L., Honigberg, L., Couch, J. A., Rothenberg, M. E., Brunstein, F., Sharma, K. R., van den Berg, L., Berry, J. D., & Glass, J. D. (2022). A Phase 1 study of GDC-0134, a dual leucine zipper kinase inhibitor, in ALS. Annals of clinical and translational neurology, . https://doi.org/10.1002/acn3.51491
Katz, Jonathan S, et al. "A Phase 1 study of GDC-0134, a dual leucine zipper kinase inhibitor, in ALS." Annals of clinical and translational neurology vol. (2022). doi: https://doi.org/10.1002/acn3.51491
Katz JS, Rothstein JD, Cudkowicz ME, Genge A, Oskarsson B, Hains AB, Chen C, Galanter J, Burgess BL, Cho W, Kerchner GA, Yeh FL, Ghosh AS, Cheeti S, Brooks L, Honigberg L, Couch JA, Rothenberg ME, Brunstein F, Sharma KR, van den Berg L, Berry JD, Glass JD. A Phase 1 study of GDC-0134, a dual leucine zipper kinase inhibitor, in ALS. Ann Clin Transl Neurol. 2022 Jan 10; doi: 10.1002/acn3.51491. Epub 2022 Jan 10. PMID: 35014217.
Copy Download .nbib Format: NLM
Experimental Observation of Hydrocarbon Growth by Resonance-Stabilized Radical-Radical Chain Reaction.

Angewandte Chemie (International ed. in English)

Couch DE, Zhang AJ, Taatjes CA, Hansen N.
PMID: 34605134
Angew Chem Int Ed Engl. 2021 Dec 20;60(52):27230-27235. doi: 10.1002/anie.202110929. Epub 2021 Nov 10.

Rapid molecular-weight growth of hydrocarbons occurs in flames, in industrial synthesis, and potentially in cold astrochemical environments. A variety of high- and low-temperature chemical mechanisms have been proposed and confirmed, but more facile pathways may be needed to explain...

Cite
Couch DE, Zhang AJ, Taatjes CA, et al. Experimental Observation of Hydrocarbon Growth by Resonance-Stabilized Radical-Radical Chain Reaction. Angew Chem Int Ed Engl. 2021;60(52):27230-27235doi: 10.1002/anie.202110929.
Couch, D. E., Zhang, A. J., Taatjes, C. A., & Hansen, N. (2021). Experimental Observation of Hydrocarbon Growth by Resonance-Stabilized Radical-Radical Chain Reaction. Angewandte Chemie (International ed. in English), 60(52), 27230-27235. https://doi.org/10.1002/anie.202110929
Couch, David E, et al. "Experimental Observation of Hydrocarbon Growth by Resonance-Stabilized Radical-Radical Chain Reaction." Angewandte Chemie (International ed. in English) vol. 60,52 (2021): 27230-27235. doi: https://doi.org/10.1002/anie.202110929
Couch DE, Zhang AJ, Taatjes CA, Hansen N. Experimental Observation of Hydrocarbon Growth by Resonance-Stabilized Radical-Radical Chain Reaction. Angew Chem Int Ed Engl. 2021 Dec 20;60(52):27230-27235. doi: 10.1002/anie.202110929. Epub 2021 Nov 10. PMID: 34605134.
Copy Download .nbib Format: NLM
UCSF ChimeraX: Structure visualization for researchers, educators, and developers.

Protein science : a publication of the Protein Society

Pettersen EF, Goddard TD, Huang CC, Meng EC, Couch GS, Croll TI, Morris JH, Ferrin TE.
PMID: 32881101
Protein Sci. 2021 Jan;30(1):70-82. doi: 10.1002/pro.3943. Epub 2020 Oct 22.

UCSF ChimeraX is the next-generation interactive visualization program from the Resource for Biocomputing, Visualization, and Informatics (RBVI), following UCSF Chimera. ChimeraX brings (a) significant performance and graphics enhancements; (b) new implementations of Chimera's most highly used tools, many with...

Cite
Pettersen EF, Goddard TD, Huang CC, et al. UCSF ChimeraX: Structure visualization for researchers, educators, and developers. Protein Sci. 2020;30(1):70-82doi: 10.1002/pro.3943.
Pettersen, E. F., Goddard, T. D., Huang, C. C., Meng, E. C., Couch, G. S., Croll, T. I., Morris, J. H., & Ferrin, T. E. (2021). UCSF ChimeraX: Structure visualization for researchers, educators, and developers. Protein science : a publication of the Protein Society, 30(1), 70-82. https://doi.org/10.1002/pro.3943
Pettersen, Eric F, et al. "UCSF ChimeraX: Structure visualization for researchers, educators, and developers." Protein science : a publication of the Protein Society vol. 30,1 (2021): 70-82. doi: https://doi.org/10.1002/pro.3943
Pettersen EF, Goddard TD, Huang CC, Meng EC, Couch GS, Croll TI, Morris JH, Ferrin TE. UCSF ChimeraX: Structure visualization for researchers, educators, and developers. Protein Sci. 2021 Jan;30(1):70-82. doi: 10.1002/pro.3943. Epub 2020 Oct 22. PMID: 32881101; PMCID: PMC7737788.
Copy Download .nbib Format: NLM
Characteristics and Spatially Defined Immune (micro)landscapes of Early-stage PD-L1-positive Triple-negative Breast Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research

Carter JM, Polley MC, Leon-Ferre RA, Sinnwell J, Thompson KJ, Wang X, Ma Y, Zahrieh D, Kachergus JM, Solanki M, Boughey JC, Liu MC, Ingle JN, Kalari KR, Couch FJ, Thompson EA, Goetz MP.
PMID: 34108182
Clin Cancer Res. 2021 Oct 15;27(20):5628-5637. doi: 10.1158/1078-0432.CCR-21-0343. Epub 2021 Jun 09.

PURPOSE: Programmed death ligand 1 [PD-(L)1]-targeted therapies have shown modest survival benefit in triple-negative breast cancer (TNBC). PD-L1EXPERIMENTAL DESIGN: From a large cohort of chemotherapy-naïve TNBC, clinicopathologic features, deconvoluted RNA immune signatures, and intraepithelial and stromal TIME (Nanostring GeoMX)...

Cite
Carter JM, Polley MC, Leon-Ferre RA, et al. Characteristics and Spatially Defined Immune (micro)landscapes of Early-stage PD-L1-positive Triple-negative Breast Cancer. Clin Cancer Res. 2021;27(20):5628-5637doi: 10.1158/1078-0432.CCR-21-0343.
Carter, J. M., Polley, M. C., Leon-Ferre, R. A., Sinnwell, J., Thompson, K. J., Wang, X., Ma, Y., Zahrieh, D., Kachergus, J. M., Solanki, M., Boughey, J. C., Liu, M. C., Ingle, J. N., Kalari, K. R., Couch, F. J., Thompson, E. A., & Goetz, M. P. (2021). Characteristics and Spatially Defined Immune (micro)landscapes of Early-stage PD-L1-positive Triple-negative Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 27(20), 5628-5637. https://doi.org/10.1158/1078-0432.CCR-21-0343
Carter, Jodi M, et al. "Characteristics and Spatially Defined Immune (micro)landscapes of Early-stage PD-L1-positive Triple-negative Breast Cancer." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 27,20 (2021): 5628-5637. doi: https://doi.org/10.1158/1078-0432.CCR-21-0343
Carter JM, Polley MC, Leon-Ferre RA, Sinnwell J, Thompson KJ, Wang X, Ma Y, Zahrieh D, Kachergus JM, Solanki M, Boughey JC, Liu MC, Ingle JN, Kalari KR, Couch FJ, Thompson EA, Goetz MP. Characteristics and Spatially Defined Immune (micro)landscapes of Early-stage PD-L1-positive Triple-negative Breast Cancer. Clin Cancer Res. 2021 Oct 15;27(20):5628-5637. doi: 10.1158/1078-0432.CCR-21-0343. Epub 2021 Jun 09. PMID: 34108182.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 198 entries